Meeting Summary
Released on: July 13, 2020
Developed by: MRCT Center Bioethics Collaborative
“COVID Trials Threatened by Shifting Surges” — MRCT Center Faculty Director, Dr. Barbara E. Bierer, discussed the state of clinical trials in the COVID-19 era, the need for clinical trial networks to be in place beforehand to speed broad multisite collaborations and the benefit of the COVID-19 Collaboration Platform in MedPageToday.
Diagnostic tests for COVID-19 are central to most proposed plans for relaxing physical distancing and related policies.
The following work by Deborah A. Zarin, MD MRCT Center Program Director and Joseph Lau, MD ,Professor Emeritus of Health Services, Policy and Practice, Center for Evidence Synthesis in Health, Brown University School of Public Health serves as a reminder about what we know and don’t know about these tests, how frequently they might produce inaccurate results, and how these inaccuracies might affect their utility in different potential scenarios. Read Paper >
Listen to Dr. Deborah Zarin, MRCT Center Program Director of Advancing the Clinical Trial Enterprise and former director of ClinicalTrials.gov with Science Magazine journalist, Charles Piller on Science Friday discussing recent investigations on ClinicalTrials.gov reporting practices.
Science Friday episode “Drug Researchers Refuse To Follow The Law. The Government Isn’t Stopping Them.”
Science Magazine article “FDA and NIH let clinical trial sponsors keep results secret and break the law” by Charles Piller featuring Dr. Deborah Zarin.
Read Now >